Seelaus Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-41,028
Closed -$4.07M 182
2019
Q3
$4.07M Sell
41,028
-275
-0.7% -$26.1K 3.56% 3
2019
Q2
$3.82M Sell
41,303
-400
-1% -$38K 3.45% 2
2019
Q1
$3.93M Sell
41,703
-2,700
-6% -$236K 3.65% 2
2018
Q4
$2.85M Buy
44,403
+2,590
+6% +$191K 3.05% 2
2018
Q3
$3.74M Buy
41,813
+1,600
+4% +$141K 3.08% 3
2018
Q2
$3.19M Sell
40,213
-1,940
-5% -$161K 2.78% 3
2018
Q1
$3.76M Buy
42,153
+16,210
+62% +$1.56M 3.23% 2
2017
Q4
$2.71M Buy
+25,943
New +$2.93M 2.35% 3

Other funds holding CELG

Seelaus Asset Management's CELG Position: Q4 2019 in Review

Seelaus Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 41,028 shares — an estimated $4.07M sold.

Seelaus Asset Management first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $4.07M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Seelaus Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Seelaus Asset Management sold 41,028 Celgene Corp shares in Q4 2019, an estimated $4.07M.
  • Seelaus Asset Management first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Seelaus Asset Management's Celgene Corp position peaked at $4.07M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Seelaus Asset Management's 13F filing for Q4 2019, filed 31 Jan 2020.